Visual acuity enhancement: Difference between revisions

Line 11:

Acuity enhancement is often accompanied by other coinciding effects such as [[color enhancement]] and [[pattern recognition enhancement]]. It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].

Acuity enhancement is often accompanied by other coinciding effects such as [[color enhancement]] and [[pattern recognition enhancement]].<ref>Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 4. https://doi.org/10.1007/s11419-014-0242-9</ref><ref>Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., ... & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International, 2014. https://dx.doi.org/10.1155/2014/734749</ref> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].

====Image examples====

@@ Line 11: / Line 11: @@
-Acuity enhancement is often accompanied by other coinciding effects such as [[color enhancement]] and [[pattern recognition enhancement]]. It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].
+Acuity enhancement is often accompanied by other coinciding effects such as [[color enhancement]] and [[pattern recognition enhancement]].<ref>Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 4. https://doi.org/10.1007/s11419-014-0242-9</ref><ref>Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., ... & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International, 2014. https://dx.doi.org/10.1155/2014/734749</ref> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].
 ====Image examples====
 <center>